Abstracts of the 2024 Canadian Association of Medical Oncologists Annual Scientific Meeting
On behalf of the Canadian Association of Medical Oncologists, we are pleased to present the abstracts of the 2024 Annual Scientific Meeting. The CAMO Annual Scientific Meeting (ASM) took place from 24-26 October 2024 in an in-person event in Ottawa, ON. Twenty-four (24) abstracts were selected for presentation as oral presentations and poster presentations. Awards for the top three (3) abstracts were presented during the ASM; they have been marked as "Award Recipient". We congratulate all presenters on their research work and contribution.
Authors
- Stephen Welch
- Desirée Hao (ORCID: https://orcid.org/0000-0003-1727-1205)
- Moira Rushton (ORCID: https://orcid.org/0000-0002-5178-2538)
- Suneil Khanna
- Alexi Campbell
- Erin Powell (ORCID: https://orcid.org/0009-0000-6244-983X)
- Sharlene Gill (ORCID: https://orcid.org/0000-0003-3306-3617)
- Maryam Soleimani
Institutions
- Canadian Medical Association (CA)
Publication Details
- Journal
- Current Oncology
- Published
- 2025-02-12
- DOI
- https://doi.org/10.3390/curroncol32020105
- Primary Topic
- Lung Cancer Treatments and Mutations
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Amgen
- Bristol-Myers Squibb
- Eli Lilly and Company
- Pfizer
- AstraZeneca
- GlaxoSmithKline
- Gilead Sciences
- Varian Medical Systems
- Regeneron Pharmaceuticals
- Illumina
- Novocure
- Ipsen Biopharmaceuticals
- BeiGene
- Incyte
- Provincial Health Services Authority
- Eisai
- Siemens Healthineers
- Ipsen
- Merck Canada
- EMD Serono
- Bristol-Myers Squibb Canada
- Amgen Canada
- Bayer Canada
- Pfizer Canada
- AbbVie Canada
- Eli Lilly Canada
- Daiichi Sankyo Europe